Natixis Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.7M | Buy |
461,098
+215,350
| +88% | +$18M | 0.05% | 337 |
|
|
2026
Q1 | $19.7M | Sell |
245,748
-7,334
| -3% | -$605K | 0.03% | 498 |
|
|
2025
Q4 | $21.6M | Sell |
253,082
-4,220
| -2% | -$346K | 0.03% | 465 |
|
|
2025
Q3 | $20M | Buy |
257,302
+20,574
| +9% | +$1.61M | 0.03% | 479 |
|
|
2025
Q2 | $18.5M | Buy |
236,728
+56,684
| +31% | +$4.23M | 0.03% | 500 |
|
|
2025
Q1 | $13.1M | Sell |
180,044
-108,399
| -38% | -$7.76M | 0.02% | 572 |
|
|
2024
Q4 | $21.4M | Buy |
288,443
+98,554
| +52% | +$6.9M | 0.04% | 418 |
|
|
2024
Q3 | $12.5M | Sell |
189,889
-58,516
| -24% | -$4.25M | 0.02% | 589 |
|
|
2024
Q2 | $22.9M | Buy |
248,405
+26,038
| +12% | +$2.31M | 0.05% | 343 |
|
|
2024
Q1 | $21.2M | Sell |
222,367
-5,470
| -2% | -$459K | 0.05% | 375 |
|
|
2023
Q4 | $17.4M | Buy |
227,837
+49,311
| +28% | +$3.43M | 0.05% | 398 |
|
|
2023
Q3 | $12.4M | Sell |
178,526
-110,428
| -38% | -$8.87M | 0.04% | 448 |
|
|
2023
Q2 | $27.3M | Buy |
288,954
+21,842
| +8% | +$1.9M | 0.08% | 248 |
|
|
2023
Q1 | $22.1M | Buy |
267,112
+16,890
| +7% | +$1.33M | 0.08% | 275 |
|
|
2022
Q4 | $18.7M | Buy |
250,222
+55,254
| +28% | +$4.26M | 0.07% | 312 |
|
|
2022
Q3 | $16.1M | Buy |
194,968
+14,943
| +8% | +$1.44M | 0.07% | 320 |
|
|
2022
Q2 | $17.1M | Buy |
180,025
+4,468
| +3% | +$463K | 0.08% | 307 |
|
|
2022
Q1 | $20.7M | Buy |
175,557
+20,841
| +13% | +$2.34M | 0.08% | 276 |
|
|
2021
Q4 | $20M | Buy |
154,716
+7,914
| +5% | +$923K | 0.08% | 286 |
|
|
2021
Q3 | $16.6M | Sell |
146,802
-6,634
| -4% | -$757K | 0.07% | 299 |
|
|
2021
Q2 | $15.9M | Buy |
153,436
+17,484
| +13% | +$1.65M | 0.07% | 296 |
|
|
2021
Q1 | $11.4M | Sell |
135,952
-7,301
| -5% | -$617K | 0.06% | 353 |
|
|
2020
Q4 | $13.1M | Buy |
143,253
+17,462
| +14% | +$1.45M | 0.08% | 292 |
|
|
2020
Q3 | $10M | Buy |
125,791
+6,927
| +6% | +$540K | 0.06% | 320 |
|
|
2020
Q2 | $8.21M | Buy |
118,864
+11,554
| +11% | +$821K | 0.05% | 360 |
|
|
2020
Q1 | $6.75M | Sell |
107,310
-50,274
| -32% | -$3.63M | 0.06% | 363 |
|
|
2019
Q4 | $12.3M | Buy |
157,584
+4,167
| +3% | +$325K | 0.09% | 269 |
|
|
2019
Q3 | $11.2M | Buy |
153,417
+2,898
| +2% | +$204K | 0.09% | 253 |
|
|
2019
Q2 | $9.27M | Sell |
150,519
-1,722
| -1% | -$104K | 0.08% | 286 |
|
|
2019
Q1 | $9.71M | Sell |
152,241
-14,076
| -8% | -$803K | 0.09% | 265 |
|
|
2018
Q4 | $8.49M | Sell |
166,317
-5,700
| -3% | -$288K | 0.08% | 260 |
|
|
2018
Q3 | $9.98M | Sell |
172,017
-67,656
| -28% | -$3.31M | 0.09% | 259 |
|
|
2018
Q2 | $11.6M | Sell |
239,673
-230,835
| -49% | -$10.8M | 0.11% | 213 |
|
|
2018
Q1 | $21.9M | Buy |
470,508
+2,529
| +0.5% | +$110K | 0.22% | 95 |
|
|
2017
Q4 | $17.6M | Buy |
467,979
+94,062
| +25% | +$3.45M | 0.18% | 124 |
|
|
2017
Q3 | $13.6M | Buy |
373,917
+124,086
| +50% | +$4.73M | 0.14% | 160 |
|
|
2017
Q2 | $9.85M | Buy |
249,831
+627
| +0.3% | +$22.9K | 0.11% | 223 |
|
|
2017
Q1 | $7.81M | Buy |
249,204
+183,228
| +278% | +$5.74M | 0.09% | 269 |
|
|
2016
Q4 | $2.06M | Sell |
65,976
-4,902
| -7% | -$159K | 0.02% | 667 |
|
|
2016
Q3 | $2.85M | Buy |
70,878
+93
| +0.1% | +$3.5K | 0.04% | 561 |
|
|
2016
Q2 | $2.35M | Buy |
70,785
+4,137
| +6% | +$142K | 0.03% | 583 |
|
|
2016
Q1 | $1.96M | Buy |
66,648
+8,796
| +15% | +$243K | 0.03% | 625 |
|
|
2015
Q4 | $1.52M | Sell |
57,852
-13,158
| -19% | -$342K | 0.03% | 668 |
|
|
2015
Q3 | $1.68M | Sell |
71,010
-5,478
| -7% | -$132K | 0.03% | 644 |
|
|
2015
Q2 | $1.82M | Sell |
76,488
-3,792
| -5% | -$85.6K | 0.03% | 659 |
|
|
2015
Q1 | $1.91M | Buy |
+80,280
| New | +$1.8M | 0.03% | 633 |
|
|
2014
Q3 | – | Sell |
-18,078
| Closed | -$259K | – | 1072 |
|
|
2014
Q2 | $259K | Buy |
18,078
+1,488
| +9% | +$20.2K | ﹤0.01% | 1198 |
|
|
2014
Q1 | $205K | Sell |
16,590
-19,152
| -54% | -$221K | ﹤0.01% | 1197 |
|
|
2013
Q4 | $392K | Sell |
35,742
-31,614
| -47% | -$356K | 0.01% | 948 |
|
|
2013
Q3 | $782K | Buy |
67,356
+624
| +0.9% | +$7.3K | 0.01% | 738 |
|
|
2013
Q2 | $747K | Buy |
+66,732
| New | +$790K | 0.01% | 730 |
|
Other funds holding EW
Natixis Advisors's EW Position: Q2 2026 in Review
Natixis Advisors increased its Edwards Lifesciences (EW) stake by 88% in Q2 2026, buying an estimated $18M and bringing the position to 461,098 shares worth $41.7M. The position accounts for 0.05% of the portfolio, ranked #337.
Natixis Advisors first reported a position in EW in Q2 2013 and has held it in 51 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Natixis Advisors held 461,098 shares of Edwards Lifesciences worth $41.7M as of Q2 2026.
- Natixis Advisors bought 215,350 Edwards Lifesciences shares in Q2 2026, an estimated $18M.
- Edwards Lifesciences made up 0.05% of Natixis Advisors's portfolio in Q2 2026, its #337 holding.
- Natixis Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.